Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
The classification of Plasma Fractionation includes Coagulation Factor, Immune Globulin, Albumin and Other, in 2017, the revenue of Coagulation Factor is 4150 million USD, with its market share 19.45%. And the revenue market share of Immune Globulin is 51.5% in 2017.
Plasma Fractionation is widely used for Immunology, Hematology and Other. The most proportion of Plasma Fractionation is for Immunology, and the proportion is about 28% in 2017.
North America is the largest sales place, with a consumption value market share nearly 39.85% in 2017. Following North America, Europe is the second largest sales place with the revenue market share of 25.52% in 2017. China is an important market of Blood Product in Asia, accounting for 14.42% revenue market share of global market.
According to this study, over the next five years the Plasma Fractionation market will register a 6.6% CAGR in terms of revenue, the global market size will reach US$ 6140 million by 2024, from US$ 4460 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Plasma Fractionation business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Fractionation market by product type, application, key manufacturers and key regions and countries.
This study considers the Plasma Fractionation value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Albumin
Immune Globulin
Coagulation Factor
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Immunology
Hematology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Plasma Fractionation consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Plasma Fractionation market by identifying its various subsegments.
Focuses on the key global Plasma Fractionation manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Plasma Fractionation with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Plasma Fractionation submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
